Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | cefmetazole | 42008 | drug-path |
| Asthma | R-HSA-444620 | map05310 | cefmetazole | 42008 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | cefmetazole | 42008 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | cefmetazole | 42008 | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | cefmetazole | 42008 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | cefmetazole | 42008 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | asiaticoside | 11954171 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | asiaticoside | 11954171 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | asiaticoside | 11954171 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | asiaticoside | 11954171 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | oxprenolol | 4631 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | oxprenolol | 4631 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | oxprenolol | 4631 | drug-path |
| Adherens junction | R-HSA-451386 | map04520 | oxprenolol | 4631 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | oxprenolol | 4631 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | oxprenolol | 4631 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | oxprenolol | 4631 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | oxprenolol | 4631 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | oxprenolol | 4631 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | oxprenolol | 4631 | drug-path |